by scv-company | Apr 8, 2024 | News
The 7th Theranostics World Congress (TWC), held from March 22-24, 2024, in the vibrant city of Santiago, Chile, marked a significant milestone in the field of personalized medicine. Prof. Dr. Rösch and Prof. Dr. Baum as the initiators of the conference, warmly...
by scv-company | Jun 27, 2022 | News
Because of COVID-19 pandemic the 6th Theranostics World Congress (TWC) 2021 was postponed and held at Jun 24-26, 2022 in Wiesbaden instead of Santiago de Chile. As the co-initiator and a member of congress committee, Prof. Dr. Frank Rösch and Prof. Dr. Richard P. Baum...
by scv-company | May 16, 2022 | News
Our CEO, Prof. Dr. Frank Rösch was honored with the 2022 Hevesy Medal Award in recognition of his outstanding contributions to radiochemistry, especially for the development of production methods for metallic radionuclides and their innovative integration for...
by scv-company | Jan 20, 2022 | News
Congratulate our CEO, Prof. Dr. Rösch, on his excellent “Pioneer lecture” about radionuclides in molecular imaging & therapy in the 35th International Austrian Winter Symposium 2022. In this congress Prof. Dr. Rösch presented how he developed the patented...
by scv-company | Jan 17, 2022 | News
The first comprehensive clinical trial around the world with our68Ga- and 177Lu-labeled theranostics pharmaceuticals based on homodimer FAP inhibitors is successfully published in Jan. 2022. In this trial 15 radioiodine-refractory differentiated thyroid cancer...
